[LGND] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
14-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 111.17%
YoY- -99.68%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 24,808 45,663 33,375 21,619 17,701 14,973 13,005 11.35%
PBT -19,871 79,226 12,071 804 7,284 901 2,025 -
Tax -4,620 11,864 3,645 160 -217,255 124 60 -
NP -15,251 67,362 8,426 644 199,165 1,280 1,965 -
Tax Rate - -14.97% -30.20% -19.90% 2,982.63% -13.76% -2.96% -
Total Cost 40,059 -21,699 24,949 20,975 -181,464 13,693 11,040 23.94%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -61.48 147.52 25.25 2.98 1,125.16 8.55 15.11 -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.81 3.19 0.40 0.03 10.01 0.06 0.10 -
EPS Diluted -0.81 2.80 0.36 0.03 9.28 0.06 0.09 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.